Last61.33 -1.30 (-2.08%)
26.17 - 73.5
52 Week Range
Technical Indicators (Daily)
Perceptive Advisors, which has topped the market in recent years, sold all its Novavax stock, and bought BridgeBio, SpringWorks, and Aldeyra stock in the first quarter....
PALO ALTO, Calif., June 14, 2021 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO), a commercial-stage biopharmaceutical company founded to discover, create, test and deliver meaningful medici...
Progress in these companies' drug development pipelines should give shareholders plenty to look forward to....
BridgeBio Pharma just hit that mark, with a jump from 79 to 83 Wednesday. Is BridgeBio stock on your radar? When looking for the best stocks to buy and watch, one factor to watch closely is relative...
BridgeBio Pharma Inc (NASDAQ: BBIO), through its affiliate QED Therapeutics Inc and Helsinn Group, has announced FDA approval for Truseltiq (infigratinib) under the accelerated approval program for ch...
Disclaimer: The data contained in Super Surge website is not necessarily real-time nor accurate and may differ from the actual market data. Prices, volumes, ratios, charts and indicators are indicative and not appropriate for trading purposes. Super Surge doesn't bear any responsibility for any trading losses you might incur as a result of using this data.